Abstract
A series of N-aromatic, N-heteroaromatic, and oxygenated N-phenylpropyl derivatives of 1-(2-benzhydryloxyethyl)-piperazine and 1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}piperazine, analogues of GBR 12909 (1a) and 12935 (1b), was synthesized and examined for their dopamine (DAT) and serotonin (SERT) transporter binding properties. One of these compounds, racemic 3-[4-(2-benzhydryloxyethyl)piperazin-1-yl]-1-(3-fluorophenyl)-propan-1-ol (33), had DAT affinity as good as, or better than, GBR 12909 and 12935, and was more selective for DAT over SERT than the GBR compounds. Both trans- (43) and cis- (47) (±)-2-(4-{2-[bis-(4-fluorophenyl)-methoxy]ethyl}piperazin-1- ylmethyl)-6-methoxy-1,2,3,4-tetrahydronaphthalen-1-ol had relatively good SERT selectivity and, as well, showed high affinity for SERT.
Original language | English |
---|---|
Pages (from-to) | 1385-1389 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 13 |
Issue number | 7 |
DOIs | |
State | Published - Apr 7 2003 |
Bibliographical note
Funding Information:The authors (LMC, NIDDK) thank the National Institute on Drug Abuse, NIH, for partial financial support of our research program. We also thank Noel Whittaker (NIDDK, NIH) for mass spectral data.
Funding
The authors (LMC, NIDDK) thank the National Institute on Drug Abuse, NIH, for partial financial support of our research program. We also thank Noel Whittaker (NIDDK, NIH) for mass spectral data.
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | |
National Institute on Drug Abuse | |
National Institute of Diabetes and Digestive and Kidney Diseases | Z01DK059501 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry